Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Monday's Intraday Session

Author: Benzinga Insights | October 09, 2023 01:31pm

Gainers

  • Acurx Pharmaceuticals (NASDAQ:ACXP) stock increased by 57.3% to $3.02 during Monday's regular session. The current volume of 4.6 million shares is 2194.2% of Acurx Pharmaceuticals's average full-day volume over the last 100 days (last updated at 13:31 EST). The market value of their outstanding shares is at $39.2 million.
  • Turnstone Biologics (NASDAQ:TSBX) stock increased by 32.05% to $3.09. As of 13:31 EST, Turnstone Biologics's stock is trading at a volume of 163.1K, which is 147.8% of its average full-day volume over the last 100 days. The company's market cap stands at $70.5 million.
  • Jin Medical International (NASDAQ:ZJYL) shares increased by 29.26% to $17.8. Trading volume for this security as of 13:31 EST is 106.4K, which is 57.0% of its average full-day volume over the last 100 days. The company's market cap stands at $137.9 million.
  • ContraFect (NASDAQ:CFRX) stock rose 24.74% to $0.5. As of 13:31 EST, this security is trading at a volume of 764.2K shares, making up 1414.1% of its average full-day volume over the last 100 days. The company's market cap stands at $2.7 million.
  • Freeline Therapeutics (NASDAQ:FRLN) stock rose 16.84% to $3.33. The current volume of 89.5K shares is 17.9% of Freeline Therapeutics's average full-day volume over the last 100 days (last updated at 13:31 EST). The market value of their outstanding shares is at $14.5 million.
  • RVL Pharmaceuticals (NASDAQ:RVLP) shares moved upwards by 15.98% to $0.15. As of 13:31 EST, this security is trading at a volume of 42.9 million shares, making up 353.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $16.3 million.

Losers

  • SeaStar Medical Holding (NASDAQ:ICU) shares decreased by 21.1% to $0.42 during Monday's regular session. Trading volume for SeaStar Medical Holding's stock is 6.0 million as of 13:31 EST. This is 92.9% of its average full-day volume over the last 100 days. The company's market cap stands at $8.2 million.
  • Addex Therapeutics (NASDAQ:ADXN) stock declined by 18.17% to $0.36. Trading volume for Addex Therapeutics's stock is 117.1K as of 13:31 EST. This is 178.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $5.7 million.
  • Etao International Co (NASDAQ:ETAO) stock declined by 16.6% to $0.18. As of 13:31 EST, Etao International Co's stock is trading at a volume of 475.0K, which is 146.3% of its average full-day volume over the last 100 days. The company's market cap stands at $18.7 million.
  • Longeveron (NASDAQ:LGVN) shares fell 15.06% to $1.58. As of 13:31 EST, Longeveron's stock is trading at a volume of 469.0K, which is 161.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $33.4 million.
  • Vaccinex (NASDAQ:VCNX) shares fell 13.67% to $0.95. As of 13:31 EST, Vaccinex's stock is trading at a volume of 2.0 million, which is 439.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $4.6 million.
  • Tango Therapeutics (NASDAQ:TNGX) shares declined by 13.1% to $9.89. Tango Therapeutics's stock is trading at a volume of 1.4 million shares as of 13:31 EST. This is 75.4% of its average full-day volume over the last 100 days. The company's market cap stands at $1.0 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ACXP ADXN CFRX ETAO FRLN ICU LGVN RVLP TNGX TSBX VCNX ZJYL

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist